The offering at Osborne Clarke is well-equipped to handle matters involving medicinal products, with a strong emphasis on commercial issues. The team’s workload includes advertising, licensing and distribution mandates, as well as assisting with matters involving medical devices. Biotech is another core area of strength for the group. Warsaw-based Agnieszka Sztoldman heads up the practice. Piotr Płachecki is well-versed in handling regulatory and compliance cases.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Excellent sector knowledge and provide very innovative solutions to their clients.’
  • ‘Agnieszka Sztoldman is an excellent life sciences lawyer, with a hands-on approach.'
  • ‘The team has excellent expertise in various life sciences matters. They are commercially oriented and very practical.’
  • ‘Agnieszka Sztoldman understands very well the needs and expectations of the client and is always able to deliver workable solutions.'

Key clients

  • Grifols
  • Perrigo International
  • Align Technology, Inc
  • IPD Analytics, LLC
  • Hempel A/S
  • Clinical Trial Solutions (CTS) sp. z o.o.
  • Lyra Therapeutics, Inc.
  • Bluefin Biomedicine Inc.
  • Velocity Clinical Research
  • LuxVet Group

Work highlights

Assisting Align Technology with regulatory matters, as well as advising on collaboration agreements.
Acting as counsel to Velocity Clinical Research, Inc. on a wide range of matters, including transactions, regulatory issues and commercial contracts.
Practice head

Agnieszka Sztoldman

Other key lawyers

Piotr Płachecki